Emcure Pharmaceuticals (India) Probability of Future Stock Price Finishing Over 1,382
| EMCURE Stock | 1,421 23.65 1.64% |
Emcure |
Emcure Pharmaceuticals Target Price Odds to finish over 1,382
The tendency of Emcure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1,421 | 90 days | 1,421 | about 38.35 |
Based on a normal probability distribution, the odds of Emcure Pharmaceuticals to move above the current price in 90 days from now is about 38.35 (This Emcure Pharmaceuticals probability density function shows the probability of Emcure Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Emcure Pharmaceuticals has a beta of 0.22 suggesting as returns on the market go up, Emcure Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Emcure Pharmaceuticals will be expected to be much smaller as well. Additionally Emcure Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Emcure Pharmaceuticals Price Density |
| Price |
Predictive Modules for Emcure Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Emcure Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Emcure Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Emcure Pharmaceuticals is not an exception. The market had few large corrections towards the Emcure Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Emcure Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Emcure Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.02 | |
β | Beta against Dow Jones | 0.22 | |
σ | Overall volatility | 53.68 | |
Ir | Information ratio | -0.03 |
Emcure Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Emcure Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Emcure Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Emcure Pharmaceuticals generated a negative expected return over the last 90 days | |
| About 87.0% of the company shares are held by company insiders |
Emcure Pharmaceuticals Technical Analysis
Emcure Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Emcure Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Emcure Pharmaceuticals. In general, you should focus on analyzing Emcure Stock price patterns and their correlations with different microeconomic environments and drivers.
Emcure Pharmaceuticals Predictive Forecast Models
Emcure Pharmaceuticals' time-series forecasting models is one of many Emcure Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Emcure Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Emcure Pharmaceuticals
Checking the ongoing alerts about Emcure Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Emcure Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Emcure Pharmaceuticals generated a negative expected return over the last 90 days | |
| About 87.0% of the company shares are held by company insiders |
Other Information on Investing in Emcure Stock
Emcure Pharmaceuticals financial ratios help investors to determine whether Emcure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Emcure with respect to the benefits of owning Emcure Pharmaceuticals security.